China Pursues Collaborative Route For Genomic, Regen Med Research
This article was originally published in PharmAsia News
Executive Summary
In line with the government’s upcoming 13th Five Year Plan, China is making efforts to promote and commercialize genomic research findings and regenerative medicine research. Recent collaborative initiatives launched jointly by the government, academia and industry are already aiming to bring clinical solutions in these areas to Chinese patients.